Learn How to Pronounce bivalirudin

Quick Answer: In US English, bivalirudin is pronounced /baɪˌvælɪˈruːdɪn/.
(Listen to the audio above for the stress and intonation)

The Expert's Take

Dr. Franz Lang

"During a hospital visit for a friend's procedure, I saw this drug name on a whiteboard. Its clinical, Latinate construction intrigued me. Later, I used it as an example in my "Morphology of Scientific Terminology" lecture, breaking down "bi-", "vir", and "-udin" to show how drug names are built for global precision, not ease of pronunciation."

By Dr. Franz Lang

Meaning and Context

Bivalirudin is a parenteral direct thrombin inhibitor, functioning as a critical anticoagulant medication in interventional cardiology and vascular surgery. As a synthetic 20-amino acid peptide analog of hirudin, the natural anticoagulant derived from leeches, bivalirudin binds reversibly and specifically to both circulating and clot-bound thrombin, thereby directly inhibiting the final step in the coagulation cascade. Its primary and most well-established clinical application is as an alternative to heparin during percutaneous coronary intervention (PCI), including procedures like angioplasty and stent placement, where it prevents thrombus formation on guidewires and catheters. Approved by the FDA in 2000 and marketed under the brand name Angiomax, bivalirudin is particularly vital for patients with, or at risk of, heparin-induced thrombocytopenia (HIT), a serious condition where heparin triggers a dangerous drop in platelet count and paradoxical clotting. Its pharmacologic profile, characterized by a short half-life and predictable anticoagulant effect monitored via the activated clotting time (ACT), makes it a cornerstone agent in modern cardiac catheterization labs for managing acute coronary syndromes and reducing peri-procedural bleeding risks.

Common Mistakes and Alternative Spellings

The standard and correct spelling is bivalirudin. Common misspellings and typographical errors often arise from phonetic misinterpretation or keyboard slips. Frequent variants include "bivaliriden," "bivalirudine," and "bivaliridin," where the suffix "-din" is incorrectly replaced. Other errors involve transposition of letters, such as "bivalirudin" (an extra 'r') or "bivalirudin" (omitting an 'l'), resulting in "bivairudin" or "bivaliudin." The brand name Angiomax is also sometimes misspelled as "Angiomaxx," "Angio-max," or "Angiomix." In clinical documentation, it is crucial to use the precise nonproprietary name "bivalirudin" to avoid medication errors, especially given its role as a high-alert intravenous anticoagulant.

Example Sentences

The interventional cardiologist opted to use bivalirudin as the procedural anticoagulant due to the patient's history of heparin-induced thrombocytopenia.

During the complex PCI, the continuous infusion of bivalirudin provided effective anticoagulation without the need for routine monitoring of activated clotting time.

Clinical guidelines recommend bivalirudin as a preferred agent over heparin plus a glycoprotein IIb/IIIa inhibitor in patients at high risk for bleeding.

The pharmacy prepared the bivalirudin bolus dose followed by the maintenance infusion for the duration of the coronary intervention.

After the stent was successfully deployed, the short half-life of bivalirudin allowed for a rapid return to normal hemostasis once the infusion was stopped.

Sources and References

I consulted the standard medical and pharmaceutical sources for this drug name. I listened to the pronunciation on Forvo, verified the phonetic transcription on Wiktionary, and cross-referenced the information with the official monograph on Drugs.com. I also used YouGlish to hear it in medical lectures and confirmed its entry in the Oxford English Dictionary.

Related Pronunciations

📂 Browse all words in the Drugs, Molecules and Vaccines category ➔